Volume 4 Issue 12 - 2020
Human Obesity and Diabetes, Is it Associated with COVID-19 Mortality
Jin-Yu Che1, Bin Xu2 and Da-Yong Lu1*
1School of Life Science, Shanghai University, Shanghai, China
2Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
*Corresponding Author: Da-Yong Lu, School of Life Science, Shanghai University, Shanghai, China.
Received: November 18, 2020; Published: November 28, 2020


The coronavirus (COVID-19, SARS-Co-2) pandemic is growing rapidly in 2020. The origin and pandemic of COVID-19 raised our concern, yet the global cooperation and confidence was devastating. To speed up global efforts against COVID-19 spread, some lines of clinical evidence and therapeutic association are discussed in the article. Obesity is a prevalence metabolic phenotype caused by either abnormal metabolic homeostasis or gene-environmental interactions. Genetic and molecular basis of obesity and diabetes associated with COVID-19 is required to improve targeted therapy against metabolic abnormality people.

Keywords: Obesity; COVID-19; Endocrinology; Human Genome; Inflammatory Factors; Viral Infection


  1. Zhu N., et al. “A novel coronavirus from patients with pneumonia in China”. The New England Journal of Medicine 8 (2020): 727-733.
  2. Ciotti M., et al. “COVID-19 outbreak: An overview”. Chemotherapy (2020).
  3. Miranda P and Getty AFP. “Coronavirus pandemic, nature’s pledge to you”. Nature 579 (2020): 471-472.
  4. Lu DY., et al. “HIV vaccination, is breakthrough underway?” Reviews on Recent Clinical Trials 2 (2016): 145-151.
  5. Lu DY., et al. “HIV vaccine for prevention and cure, a mission possible”. Reviews on Recent Clinical Trials 4 (2016): 290-296.
  6. Callaway E. “Should scientists infect healthy people with the coronavirus to test vaccines?” Nature (2020): 580.
  7. Callaway E. “Coronavirus vaccines five key question as trial begin”. Nature 578 (2020): 481.
  8. Blaising J., et al. “Arbidolas as a broad-spectrum antiviral: an update”. Antiviral Research 107 (2014): 84-94.
  9. Vincent MJ., et al. “Chloroquine is a potent inhibitor of SARS coronavirus infection and spread”. Virology Journal 1 (2005): 69.
  10. Kebede T., et al. “Potential drug options for treatment of COVID-19, a review”. Coronaviruses1 (2020): 42-48.
  11. Doshi GM., et al. “Critical insight into the attributes of emerging novel coronavirus (COVID-19):in India and across the world”. Coronaviruses1 (2020): 49-56.
  12. Pattanayak S. “Alternative to antibiotics from herbal origin-outline of a comprehensive research project”. Current Pharmacogenomics Personalized Medicine 1 (2018): 9-62.
  13. Wang YX., et al. “Utilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19”. European Review for Medical and Pharmacological Sciences 24 (2020): 3360-3384.
  14. Lu DY and Lu TR. “Herbal medicine in new era”. Hospice Palliative Medicine International Journal 4 (2019): 125-130.
  15. Lu DY and Lu TR. “Drug discoveries from natural resources”. Journal Primary Health Care and General Practice 1 (2019): 28.
  16. Lu DY., et al. “Obesity, risks and managements”. Metabolomics1 (2018): e155.
  17. Lu DY., et al. “An overview of obesity”. Metabolomics2 (2018): 200.
  18. Jainta N., et al. “Infection diseases and vaccination in patients with diabetes”. EC Diabetes and Metabolic Research 3 (2019): 91-97.
  19. Lu DY., et al. “Pathology and treatments of obesity”. Trends in Medicine 5 (2018): 157.
  20. Lu DY., et al. “Obese study, keep up the momentum”. International Archives of Endocrinology Clinical Research 1 (2018): 4-8.
  21. Lu DY., et al. “Type 2 diabetes study, introduction and perspective”. The Open Diabetes Journal 8 (2018): 13-21.
  22. Lu DY., et al. “Type 2 diabetes treatment and drug development study”. The Open Diabetes Journal 8 (2018): 22-33.
  23. Brestoff JJR and Artis D. “Immune regulation of metabolic homeostasis in health and disease”. Cell 161 (2015): 146-160.
  24. Yanai H. “VLDL is the leading actor in lipid abnormality in patients with diabetes and obesity”. Journal of Endocrinology and Metabolism 4 (2017): 101-102.
  25. Steculorum SM., et al. “Hypothalamic UDP increases in obesity and promotes feeding via P2Y6-dependent activation of AgRP neurons”. Cell 162 (2015): 1404-1417.
  26. Lee YS., et al. “Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity”. Cell 157 (2014): 1339-1352.
  27. Quarta C., et al. “Epigenetic ON/OFF switches for obesity”. Cell 164 (2016): 341-342.
  28. Dalgaard K., et al. “Trim28 haploinsufficiency triggers bi-stable epigenetic obesity”. Cell 164 (2016): 353-364.
  29. Lu DY., et al. “Mini-review of obesity, etiology progresses and different therapeutics”. EC Diabetes and Metabolic Research 3 (2019): 98-102.
  30. Lu DY., et al. “Human obesity, pathological and therapeutic advances”. EC Pharmacology and Toxicology 4 (2019): 231-238.
  31. Nzuza S., et al. “Highly active antiretroviral therapy-associated metabolic syndrome and lipodystrophy: pathophysiology and current therapeutic interventions”. Journal of Endocrinology and Metabolism 4 (2017): 103-116.
  32. Correa-Giannella ML and Machado UF. “SLC2A4 gene: a promising target for pharmacogenomics of insulin resistance”. Pharmacogenomics 8 (2013): 847-850.
  33. Van Der Klaauw AA and Farooqi IS. “The hunger genes: pathways to obesity”. Cell 161 (2015): 119-132.
  34. Putta S., et al. “Diabetes mellitus and male aging, pharmacotherapeutics and clinical implications”. Current Pharmaceutical Design 41 (2017): 6321-6346.
  35. Lu DY., et al. “Drug combinations in cancer treatment”. Clinical Experimental Pharmacology 3 (2013): 134.
  36. Lu DY., et al. “HAART in HIV/AIDS treatments, future trends”. Infectious Disorders-Drug Targets1 (2018): 15-22.
  37. Lu DY., et al. “Drug combination in clinical cancer treatment”. Reviews on Recent Clinical Trials3 (2017): 202-211.
  38. Lu DY., et al. “Anticancer drug combination, how far we can go through?” Anti-Cancer Agents in Medicinal Chemistry 1 (2017): 21-28.
  39. Lu DY., et al. “Anticancer drug combinations, studies from different pathways”. Cell and Developmental Biology5 (2015): 166.
Citation: Da-Yong Lu., et al. “Human Obesity and Diabetes, Is it Associated with COVID-19 Mortality”. EC Diabetes and Metabolic Research 4.12 (2020): 01-03.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.